Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review.
about
Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreasNon-functional neuroendocrine tumors of the pancreas: Advances in diagnosis and managementUpdate on surgical treatment of pancreatic neuroendocrine neoplasmsManagement of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphologyPancreastatin predicts survival in neuroendocrine tumors.ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms of the digestive system: well-differentiated pancreatic non-functioning tumors.Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumorsGuidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours (NETs)Treatment of malignant pancreatic neuroendocrine neoplasms: middle-term (2-year) outcomes of a prospective observational multicentre study.Survival impact of malignant pancreatic neuroendocrine and islet cell neoplasm phenotypesSystematic review of resecting primary tumor in MNETs patients with unresectable liver metastases.Treatment of liver metastases in patients with digestive neuroendocrine tumors.Systematic review of resection of primary midgut carcinoid tumour in patients with unresectable liver metastases.Novel molecular targets for the treatment of gastroenteropancreatic endocrine tumors: answers and unsolved problemsSurgical management of pancreatic neuroendocrine neoplasms.Nordic guidelines 2014 for diagnosis and treatment of gastroenteropancreatic neuroendocrine neoplasms.Meta-analysis of Liver Resection Versus Nonsurgical Treatments for Pancreatic Neuroendocrine Tumors with Liver Metastases.Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine Tumors.Multimodal Treatment of Vasoactive Intestinal Polypeptide-producing Pancreatic Neuroendocrine Tumors with Liver MetastasesThe Role of Cytotoxic Chemotherapy in Advanced Pancreatic Neuroendocrine Tumors.Resection of the Primary Tumor Followed by Peptide Receptor Radionuclide Therapy as Upfront Strategy for the Treatment of G1-G2 Pancreatic Neuroendocrine Tumors with Unresectable Liver Metastases.Liver transplantation for metastatic neuroendocrine tumors: Outcomes and prognostic variables.Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based, propensity score-matched survival analysis.Role of palliative resection of the primary pancreatic neuroendocrine tumor in patients with unresectable metastatic liver disease: a systematic review and meta-analysis.Neutrophil-to-lymphocyte ratio predicts metachronous liver metastasis of pancreatic neuroendocrine tumors.The added value of 68Ga-DOTA-TATE-PET to contrast-enhanced CT for primary site detection in CUP of neuroendocrine origin.[Gastroenteropancreatic neuroendocrine tumors : targeted diagnostics and therapy].Surgical treatment of sporadic pancreatic neuroendocrine tumors: a state of the art review.
P2860
Q26752757-FCB83186-08B2-4B01-B119-E1FFDD321CB0Q26795597-803FD0B1-0CB7-4842-B582-2F740B73146EQ26864361-2EA6DE90-DE92-4B36-ADA9-D6264103D93EQ28078501-363848C7-8846-476B-9878-99C60561FE6CQ34016884-7EC679D6-00FC-48BF-A919-D748D6AEE7CEQ34248466-46A297DB-3FC0-47AB-833F-BE7348D8BD55Q34680094-0801E475-B4AD-4C40-A106-D8BED8AC4DF4Q35760798-0A497EC2-6E20-4B59-A9E3-8DA72DAA4E5FQ37350299-F1E09D5D-A0A1-42D4-82D9-6466C7471CF2Q37460268-02040BE4-6133-448C-AF2E-6178961DE0B3Q37725626-AC0C0E46-3576-466B-ABD8-16E32BD83C4FQ38029275-39496558-0C29-480A-8693-1587A95EC9DFQ38042860-452D3AA4-97ED-4EF7-B74F-BC739787FCCDQ38076275-3324A6BA-9535-4234-8D25-9C12B68E8BF0Q38198509-9E509975-8459-4FA8-91D5-9D6464CBD436Q38241601-F993DB60-28DB-4F20-A2DD-8C2D957C602CQ38537928-CA8ACDF4-2B7B-43AB-A3AF-6C7A20E7B98BQ38581192-EE32C22E-0119-49F6-9082-824CB8FA5BD8Q39156920-3654BF11-B9C7-4A65-9BCE-CA0F56C1DFCBQ39448012-EA7E192A-996B-40DF-81EB-AF7F0825882CQ40587447-4B7AD9AB-B550-4F17-B361-A9DB6B3EE124Q40740575-FC1BC7EF-5BAF-41B3-A080-4D950CAF4854Q41561189-CC2DD325-76F1-41EA-BD07-3DA733DAA01BQ52674883-5CFF46B4-CFBA-4006-A82D-3C4CA458234CQ52892463-69468901-FE49-4AEA-AAD8-C8B7B5852BADQ52980637-F793D843-2CBE-4E06-9DD4-404C456B0B46Q53057084-D029B49B-3B0C-499A-8CD9-0B48DB3559AFQ55192213-C86FE228-2418-463A-A2D9-D98476F6200A
P2860
Role of resection of the primary pancreatic neuroendocrine tumour only in patients with unresectable metastatic liver disease: a systematic review.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 February 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of resection of the prima ...... disease: a systematic review.
@en
Role of resection of the prima ...... disease: a systematic review.
@nl
type
label
Role of resection of the prima ...... disease: a systematic review.
@en
Role of resection of the prima ...... disease: a systematic review.
@nl
prefLabel
Role of resection of the prima ...... disease: a systematic review.
@en
Role of resection of the prima ...... disease: a systematic review.
@nl
P2093
P2860
P356
P1433
P1476
Role of resection of the prima ...... disease: a systematic review.
@en
P2093
Gabriele Capurso
Gianfranco Delle Fave
Letizia Boninsegna
Maria Rinzivillo
Rossella Bettini
P2860
P304
P356
10.1159/000324770
P577
2011-02-25T00:00:00Z